What Are GLP-1 Medications?
GLP-1 receptor agonists are a class of prescription medications that mimic a naturally occurring hormone called glucagon-like peptide-1 (GLP-1). This hormone is released from your gut after you eat and plays several important roles in regulating blood sugar and appetite.
The most well-known GLP-1 medications include:
- Semaglutide (brand names: Ozempic for diabetes, Wegovy for weight loss, Rybelsus as an oral tablet)
- Tirzepatide (Mounjaro for diabetes, Zepbound for weight loss) — technically a dual GLP-1/GIP agonist
- Liraglutide (Victoza for diabetes, Saxenda for weight loss)
- Dulaglutide (Trulicity)
- Exenatide (Byetta, Bydureon)
How They Work: The Three Main Mechanisms
1. Slowing Gastric Emptying
GLP-1 medications slow the rate at which food leaves your stomach. This means you feel full for longer after eating, which naturally reduces how much you eat at subsequent meals. This effect is one of the primary reasons these medications cause weight loss.
2. Reducing Appetite Signals in the Brain
GLP-1 receptors are found not just in the gut, but also in the brain — particularly in areas that control hunger and reward. When GLP-1 medications activate these receptors, they reduce appetite signals, decrease food cravings, and lower the "reward value" of food. Many patients report that food simply becomes less interesting while on these medications.
3. Stimulating Insulin and Suppressing Glucagon
In people with type 2 diabetes, GLP-1 medications stimulate the pancreas to release more insulin when blood sugar is high. Crucially, this effect is glucose-dependent — meaning the medications only trigger insulin release when blood sugar is elevated, which significantly reduces the risk of hypoglycemia (dangerously low blood sugar) compared to older diabetes drugs like sulfonylureas.
They also suppress glucagon, a hormone that raises blood sugar by signaling the liver to release stored glucose.
What Results Can Patients Expect?
Clinical trial data provides a useful benchmark:
| Medication | Average Weight Loss | HbA1c Reduction |
|---|---|---|
| Semaglutide 2.4mg (Wegovy) | ~15% of body weight | ~1.6% |
| Tirzepatide 15mg (Zepbound) | ~21% of body weight | ~2.3% |
| Liraglutide 3mg (Saxenda) | ~8% of body weight | ~1.1% |
Results vary significantly between individuals. Factors that influence response include starting weight, diet quality, physical activity, and genetic variation in GLP-1 receptor sensitivity.
Common Side Effects
The most common side effects are gastrointestinal and typically occur when starting the medication or increasing the dose:
- Nausea (most common, affects 30–50% of patients)
- Vomiting
- Diarrhea or constipation
- Reduced appetite (often considered a desired effect)
These side effects usually improve within 4–8 weeks as the body adjusts. Starting at a low dose and gradually increasing (as prescribed) significantly reduces their severity.
Who Are GLP-1 Medications Right For?
GLP-1 medications are FDA-approved for:
- Type 2 diabetes — most GLP-1 drugs are approved as add-on therapy when metformin alone is insufficient
- Chronic weight management — semaglutide (Wegovy) and tirzepatide (Zepbound) are approved for adults with a BMI ≥30, or ≥27 with a weight-related condition
They are not appropriate for people with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), due to a theoretical risk observed in animal studies.
Cost and Access
GLP-1 medications are among the most expensive prescription drugs in the United States. Without insurance, monthly costs range from $800–$1,400. However:
- Manufacturer savings programs (Novo Nordisk, Eli Lilly) can reduce costs to $25–$99/month for eligible patients
- Many insurance plans cover GLP-1 drugs for diabetes but not for weight loss
- Generic versions are not yet available but are expected after 2031
The Bottom Line
GLP-1 medications represent a genuine advance in treating both type 2 diabetes and obesity. They work through multiple complementary mechanisms — slowing digestion, reducing appetite, and improving blood sugar regulation — and have demonstrated cardiovascular benefits in large clinical trials.
If you are considering a GLP-1 medication, discuss your full medical history with your prescriber, including any history of pancreatitis, thyroid conditions, or kidney disease. These medications are most effective when combined with dietary changes and increased physical activity.
This article is for informational purposes only. Always consult a licensed healthcare provider before starting any new medication.
Save up to 80% on this medication
Use a free RxGo discount card at 67,000+ pharmacies — no sign-up, no insurance needed.
About the Author
Dr. Rafael Morales, PharmD, BCACP, CDE
Clinical Pharmacist — Diabetes & Metabolic Disease
Dr. Rafael Morales is a board-certified ambulatory care pharmacist and certified diabetes educator at Mayo Clinic with over 15 years of experience managing patients with type 2 diabetes, obesity, and metabolic syndrome. He completed his PharmD at the University of Texas at Austin and his residency at UT Southwestern Medical Center. Dr. Morales has been involved in clinical trials evaluating GLP-1 receptor agonists and dual GIP/GLP-1 agonists, and he serves on the American Diabetes Association's clinical practice committee. His reviews focus on ensuring pharmacological accuracy, appropriate patient selection criteria, and evidence-based dosing guidance.
View full profile on our Editorial Team page →Zova Health
Protect the Architecture · GLP-1 Protocol
Don't just lose weight. Preserve your health.
GLP-1 medications can cause up to 39% muscle loss alongside fat. Zova's evidence-based protocol — validated by Lancet Diabetes & Endocrinology 2024 — combines AI-powered leucine tracking, injection-day adaptive nutrition, and progressive resistance training to reduce that to just 8.7%.
No credit card. No commitment. Early access only.
Clinical validation:
Structured protein protocols preserved 78% more lean mass vs. standard GLP-1 use alone. — Lancet Diabetes & Endocrinology, 2024
Get the RxGo app — free prescription discounts on the go
Works at 67,000+ pharmacies · No membership needed